Glyoxalase I inhibition by TLSC702 sensitizes glyoxalase I-dependent cancer cells to doxorubicin-induced cell death
The Journal of Toxicological Sciences · 2026
DOI: 10.2131/jts.51.565 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Toxicological Sciences, 2026. Verfasst von Haruka Mori und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Tokyo University of Science. Hauptthemen laut MEDLINE: Doxorubicin, Lactoylglutathione Lyase, Cell Death, Antibiotics, Antineoplastic. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, Tokyo University of Science.
Zitieren
APA
Mori, H., & Takasawa, R. (2026). Glyoxalase I inhibition by TLSC702 sensitizes glyoxalase I-dependent cancer cells to doxorubicin-induced cell death. The Journal of Toxicological Sciences. https://doi.org/10.2131/jts.51.565
Vancouver
Mori H, Takasawa R. Glyoxalase I inhibition by TLSC702 sensitizes glyoxalase I-dependent cancer cells to doxorubicin-induced cell death. The Journal of Toxicological Sciences. 2026. doi:10.2131/jts.51.565
BibTeX
@article{Mori2026,
author = {Mori, Haruka and Takasawa, Ryoko},
title = {Glyoxalase I inhibition by TLSC702 sensitizes glyoxalase I-dependent cancer cells to doxorubicin-induced cell death},
journal = {The Journal of Toxicological Sciences},
year = {2026},
doi = {10.2131/jts.51.565}
}
EUVIMED